Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Systemic therapy for metastatic renal-cell carcinoma
Kidney cancers have been extensively studied, and insights from an increased
understanding of tumor biology have led to increases in survival rates. Therapies aimed at …
understanding of tumor biology have led to increases in survival rates. Therapies aimed at …
Clinical review on the management of metastatic renal cell carcinoma
J Tran, MC Ornstein - JCO Oncology Practice, 2022 - ascopubs.org
Renal cell carcinomas vary considerably in their tumor biology and disease course, which is
reflected in the range of treatment paradigms in localized and metastatic renal cell …
reflected in the range of treatment paradigms in localized and metastatic renal cell …
Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology
The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging,
treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage …
treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage …
Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the
clinical management of patients with clear cell and non–clear cell renal carcinoma. These …
clinical management of patients with clear cell and non–clear cell renal carcinoma. These …
Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity
B Shuch, A Amin, AJ Armstrong, JN Eble, V Ficarra… - European urology, 2015 - Elsevier
Context Once believed to represent a uniform malignant phenotype, renal cell carcinoma
(RCC) is now viewed as a diverse group of cancers that arise from the nephron. Objective …
(RCC) is now viewed as a diverse group of cancers that arise from the nephron. Objective …
Systemic therapy for non–clear cell renal cell carcinomas: a systematic review and meta-analysis
Context Clinical data supporting the use of targeted agents for the treatment of metastatic
renal cell carcinoma (RCC) are based predominantly on patients with clear cell histology …
renal cell carcinoma (RCC) are based predominantly on patients with clear cell histology …
Cabozantinib as first-line treatment in patients with metastatic collecting duct renal cell carcinoma: Results of the BONSAI trial for the Italian network for research in …
G Procopio, P Sepe, M Claps, S Buti… - JAMA …, 2022 - jamanetwork.com
Importance Metastatic collecting duct carcinoma (mCDC) is a rare type of non–clear cell
renal cell carcinoma (ncRCC) with poor prognosis and no standard treatments. Despite …
renal cell carcinoma (ncRCC) with poor prognosis and no standard treatments. Despite …
[PDF][PDF] Renal cell carcinoma of variant histology: biology and therapies
The term variant histology renal cell carcinomas (vhRCC), also known as non-clear cell
RCCs, refers to a diverse group of malignancies with distinct biologic and therapeutic …
RCCs, refers to a diverse group of malignancies with distinct biologic and therapeutic …
Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling
Background Collecting duct carcinoma (CDC) is a rare type of renal cell carcinoma (RCC)
originating from the renal medulla. Clinical outcomes are poor, and there are no consensus …
originating from the renal medulla. Clinical outcomes are poor, and there are no consensus …
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma …
Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma are rare
aggressive neoplasms of putative distal nephron origin. First described in 1949, case reports …
aggressive neoplasms of putative distal nephron origin. First described in 1949, case reports …